Skip to main content
Equibles
RDZN logo

RDZN · Roadzen Inc.

Track RDZN — free

Use RDZN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.29 -0.05 (-3.73%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Going-concern doubt — cleared Aug 13, 2026

The latest filing states the doubt was alleviated.

“These events, among others, raise substantial doubt over the Company’s ability to continue as a going concern for a reasonable period of time. ... management believes it has formulated and is executing a viable plan to obtain sufficient liquidity to meet obligations as they fall due over the next 12 months. As a result, management expects to alleviate the substantial doubt regarding the Company’s ability to continue as a going concern.”
View the 10-Q filed Aug 13, 2026
Market Cap
$114.12M
Shares
85.17M

RDZN metrics

56 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.29
Market cap
$114.12M

Price action

19 metrics
Price change (1W)
-12.8%
Price change (30D)
+4.0%
Price change (3M)
-24.6%
Price change (6M)
+0.0%
Price change (YTD)
-46.5%
Price change (1Y)
+35.8%
Trailing year
Price change (5Y)
—
52-week high
$2.41
52-week low
$0.83
Change from 52-week high
-46.5%
Change from 52-week low
+54.9%
Annualized volatility
93.2%
Beta
1.7
RSI (14D)
40.6
Price vs SMA 50
-2.3%
Price vs SMA 200
-15.4%
Avg volume (3M)
490,353
Relative volume
0.5
Average dollar volume
$707,615

Company

3 metrics
Sector
Technology
Industry
Software - Application
Shares outstanding
85.17M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
2.2×
reciprocal yield 44.9%
EV / EBITDA
—
EV / EBIT
—
P / sales
1.9×
reciprocal yield 52.9%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-24.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
60.7%
Operating margin
-21.6%
Trailing 12 months
Net margin
-46.9%
Gross profit (TTM)
—
Operating profit (TTM)
−$13.02M
Net income (TTM)
−$28.30M
Trailing 12 months
Diluted EPS (TTM)
$-0.36
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-3.08

Growth

11 metrics
Revenue growth YoY
+49.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$60.35M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+11.3%
Year over year · more shares
Revenue CAGR (3Y)
+307.9%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-59.3%
Debt / equity
—
Current ratio
0.4
EBITDA (TTM)
−$10.17M
Free cash flow (TTM)
—
Quick ratio
0.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$20.21M
Latest balance sheet
Cash & equivalents
$6.00M
Total assets
$47.72M
Total debt
$26.22M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$22.82M
Capital expenditures (TTM)
—
R&D (TTM)
$745,936
SG&A (TTM)
—
Stock compensation (TTM)
$501,824
R&D / revenue
1.2%
Stock compensation / revenue
0.8%

Ownership (13F)

3 metrics
13F filers
70
13F filer change QoQ
+20
Institutional ownership
11.9%

Short interest

3 metrics
Short interest
2.4%
Latest settlement · 9.5 days to cover
Days to cover
9.5d
Short-squeeze score
53 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1868640 CUSIP G7606H108 13F (30d) 42 filings 42 filers Visit website Investor relations